Skip to main content

Table 4 Percentage reduction of whitefly, Bemisia tabaci, on capsicum plant treated with indigenous and commercial bioformulations under protected cultivation (2017, 2018)

From: Management of the aphid, Myzus persicae (Sulzer) and the whitefly, Bemisia tabaci (Gennadius), using biorational on capsicum under protected cultivation in India

Treatments

Dose (g or ml/l)

Percent reduction over control*(mean ± SE)

I Spray

II Spray

III Spray

3DAS

7DAS

10DAS

3DAS

7DAS

10DAS

3DAS

7DAS

10DAS

Beauveria bassiana

Bb-B1

8

14.5 ± 6.0a

18.5 ± 8.2c

22.3 ± 8.3b

26.3 ± 3.1c

29.4 ± 3.0d

31.2 ± 5.4e

40.2 ± 7.9e

40.4 ± 9.5e

40.9 ± 12.0d

10

15.0 ± 9.0a

19.5 ± 8.0bc

24.8 ± 8.7ab

30.0 ± 10.7bc

33.5 ± 10.0cd

33.8 ± 7.9de

42.7 ± 6.4de

43.2 ± 4.9de

43.8 ± 6.4d

12

15.6 ± 5.4a

23.0 ± 7.3abc

28.2 ± 6.3ab

33.6 ± 9.4abc

35.8 ± 8.8bcd

37.6 ± 11.1cde

45.1 ± 8.1cde

45.8 ± 8.5de

46.5 ± 9.7d

Lecanicillium lecanii

MTCC 956

8

21.9 ± 5.2a

27.3 ± 3.8abc

31.3 ± 4.4ab

34.7 ± 5.4abc

41.6 ± 1.2abcd

47.3 ± 0.5abcde

55.3 ± 1.2abcde

56.3 ± 4.0abcde

57.2 ± 0.9abcd

10

23.0 ± 4.0a

29.0 ± 2.0abc

33.7 ± 2.6ab

40.8 ± 3.8abc

46.8 ± 1.8abc

51.4 ± 0.6abc

58.3 ± 1.5abcd

61.2 ± 3.2abcd

60.0 ± 4.8abcd

12

26.6 ± 7.4a

31.0 ± 6.4abc

35.9 ± 5.4ab

44.4 ± 2.7abc

49.0 ± 3.6ab

53.1 ± 2.5abc

60.3 ± 3.0abcd

61.8 ± 3.8abcd

61.6 ± 4.7abcd

Beauveria bassiana

Commercial formulation

8

16.1 ± 2.1a

20.4 ± 4.8abc

22.8 ± 5.8b

30.9 ± 2.5bc

35.4 ± 2.6bcd

38.6 ± 3.3bcde

47.2 ± 4.0bcde

47.9 ± 3.9cde

48.6 ± 5.4cd

10

16.5 ± 5.0a

21.3 ± 3.4abc

24.2 ± 2.4ab

31.8 ± 2.6abc

36.8 ± 3.6bcd

39.6 ± 7.1bcde

48.6 ± 6.3bcde

49.3 ± 2.7bcde

50.2 ± 5.1bcd

12

16.9 ± 8.6a

22.7 ± 7.2abc

25.9 ± 6.0ab

34.1 ± 11.5abc

40.0 ± 9.3bcd

43.1 ± 11.8abcde

51.6 ± 12.7bcde

51.1 ± 12.8bcde

52.0 ± 11.8bcd

Metarhizium anisopliae

Commercial formulation

8

15.5 ± 3.5a

19.6 ± 6.5c

23.2 ± 6.6b

30.7 ± 2.7bc

34.8 ± 3.6cd

40.0 ± 3.5bcde

47.4 ± 0.7bcde

45.0 ± 1.9de

45.4 ± 3.0d

10

16.0 ± 2.1a

21.0 ± 0.5abc

24.9 ± 3.5ab

32.5 ± 2.6abc

36.0 ± 4.0bcd

40.9 ± 3.8abcde

48.6 ± 6.0bcde

46.5 ± 10.3de

47.4 ± 11.0cd

12

16.4 ± 3.3a

21.0 ± 4.2abc

25.2 ± 4.4ab

33.3 ± 6.9abc

37.9 ± 4.5bcd

41.2 ± 5.1abcde

50.0 ± 5.8bcde

47.8 ± 4.7cde

48.7 ± 4.6cd

Lecanicillium lecanii

Commercial formulation

8

19.3 ± 4.4a

26.0 ± 4.2abc

30.0 ± 4.9ab

33.4 ± 6.7abc

40.2 ± 2.4abcd

45.9 ± 1.4abcde

54.0 ± 1.1abcde

54.8 ± 2.8bcde

55.8 ± 2.0abcd

10

20.1 ± 3.8a

27.3 ± 2.6abc

32.3 ± 2.7ab

39.4 ± 5.3abc

45.5 ± 3.4abcd

50.0 ± 1.1abcd

57.0 ± 1.8abcde

56.7 ± 4.5abcde

57.0 ± 7.0abcd

12

22.6 ± 6.2a

29.7 ± 6.2abc

34.6 ± 5.4ab

41.6 ± 0.7abc

46.2 ± 2.4abc

51.6 ± 1.5abc

59.0 ± 4.1abcd

58.9 ± 0.9abcde

60.1 ± 5.7abcd

Azadirachtin 1% (10,000 ppm)

4

27.6 ± 2.4a

32.2 ± 1.2abc

37.1 ± 1.8ab

46.0 ± 2.7abc

49.3 ± 2.4ab

52.4 ± 1.4abc

62.1 ± 2.8abc

65.4 ± 0.7abc

68.5 ± 2.0abc

5

30.9 ± 8.3a

36.6 ± 6.5ab

40.0 ± 7.0ab

47.0 ± 6.5ab

51.6 ± 4.1ab

56.0 ± 4.2ab

63.8 ± 3.7ab

67.1 ± 1.1ab

71.0 ± 1.6ab

Chemical check (malathion 50 EC)

4

32.3 ± 4.9a

38.3 ± 3.3a

42.2 ± 4.4a

50.7 ± 3.6a

55.5 ± 3.1a

58.6 ± 2.1a

70.4 ± 2.2a

73.2 ± 0.3a

78.2 ± 2.8a

F values

 

1.1

1.3

1.4

1.5

2.4

2.4

2.3

2.8

2.5

P

 

0.40

0.22

0.20

0.14

0.01

0.01

0.01

0.01

0.01

  1. Mean mortality (%) ± standard error of B. tabaci recorded at different time intervals (DAS days after spray) for bioassays performed with different commercial and indigenous strains
  2. Treatment columns bearing different alphabets are significantly different from other treatments according to Duncan test (P = 0.05)
  3. *Calculated as per Henderson and Tilton (1955) formula